Author

Mirza Jahic

Institution: Eurofins (United States)

Observed institutions: Eurofins (United States), Optivia Biotechnology (United States)

ORCID: 0009-0000-6899-4302

Observed ORCID: 0009-0000-6899-4302

OpenAlex ID: A5109778449

Interactions of bilastine, a new oral H1antihistamine, with human transporter systems

2012 · Maria Luisa Lucero, Ana Gonzalo, et al. · Drug and Chemical Toxicology · 44

Assessment of the Drug Interaction Potential of Unconjugated and GalNAc3-Conjugated 2′-MOE-ASOs

2017 · Colby S. Shemesh, Rosie Z. Yu, et al. · Molecular Therapy — Nucleic Acids · 40

Lack of Interactions Between an Antisense Oligonucleotide with 2′- O -(2-Methoxyethyl) Modifications and Major Drug Transporters

2016 · Rosie Z. Yu, Mark S. Warren, et al. · Nucleic Acid Therapeutics · 26

Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures

2025 · Antonia C. Darragh, Andrew M. Hanna, et al. · ACS Pharmacology & Translational Science · 8

Comprehensive Analysis of Clinically Discontinued Compounds Using an In Vitro Secondary Pharmacology Panel to Predict Potential Safety Risks during Drug Development

2025 · Verena Albert, Danielle E. Skinner, et al. · ACS Pharmacology & Translational Science · 2

Wee1-targeting inhibitors: From virtual screening to lead discovery

2026 · Jochem Nelen, Bidisha Sarkar, et al. · Bioorganic & Medicinal Chemistry · 1

Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”

2026 · Antonia C. Darragh, Andrew M. Hanna, et al. · ACS Pharmacology & Translational Science

Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”

2026 · Antonia C. Darragh, Andrew M. Hanna, et al. · ACS Pharmacology & Translational Science

Perspective: The Re-emergence of Covalent Modulation in Drug Discovery

2025 · Mirza Jahic

Works count: 9

Citation count: 121

H-index: 4

I10-index: 3